prodchem
Aug 20, 2026
The U.S. Food and Drug Administration (FDA) is undergoing a leadership transition in 2026, with Kyle A. Diamantas serving as Acting Commissioner of Food and Drugs since May 15, 2026, following Martin Makary's tenure.
For the agrochemical industry, the implications are more nuanced than the headline may suggest. The U.S. Environmental Protection Agency (EPA) is the primary federal agency responsible for pesticide registration under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). However, FDA remains relevant to pesticide-related food safety issues because the Federal Food, Drug, and Cosmetic Act (FFDCA) governs pesticide tolerances and related food-safety requirements.
As a result, changes in FDA leadership can indirectly influence the regulatory environment in which crop protection products are developed, registered, and marketed.
Martin Makary served as FDA Commissioner from March 25, 2025, until May 13, 2026. FDA's current leadership information identifies Kyle Diamantas as Acting Commissioner, with his appointment beginning May 15, 2026.
Diamantas previously served as FDA's Deputy Commissioner for Food, where he led the Human Foods Program and oversaw food safety activities, risk prioritization, policy initiatives, and major food-related responses.
This background is particularly relevant to agrochemical stakeholders because pesticide regulation intersects with food safety whenever residues may occur on agricultural commodities.
It is important to distinguish the responsibilities of FDA and EPA.
Under FIFRA, EPA regulates pesticides sold or distributed in the United States. EPA evaluates pesticide ingredients, proposed uses, exposure, environmental effects, and other scientific information before determining whether a product can be registered.
EPA's Office of Pesticide Programs manages the principal pesticide registration framework, including conventional pesticides, biopesticides, antimicrobial pesticides, and inert ingredients. The agency also provides registration manuals, data requirements, labeling guidance, and electronic submission processes.
Therefore, an FDA leadership change does not directly replace or control the EPA pesticide registration process.
FDA's relevance comes primarily through food safety.
When a pesticide is used on crops intended for human or animal consumption, regulators need to establish that residues are acceptable under applicable food-safety requirements. EPA's pesticide framework operates alongside provisions of the FFDCA concerning pesticide tolerances and exemptions.
EPA explicitly identifies both FIFRA and FFDCA as major federal statutes governing pesticides. Its registration process considers the potential effects of pesticide use on human health and the environment.
This creates an important regulatory connection between the two agencies.
For agrochemical companies, the registration pathway therefore involves more than demonstrating that an active ingredient controls a pest. Companies must also generate data capable of supporting regulatory conclusions concerning residues, exposure, safety, and environmental effects.
The current FDA leadership structure makes food policy an important area for agrochemical companies to monitor.
Diamantas previously led the Human Foods Program, which covers FDA activities involving nutrition and food safety.
This does not mean FDA will begin directly registering crop protection products. Instead, changes in food-safety priorities, scientific standards, monitoring practices, or interagency coordination could influence the broader environment surrounding agricultural chemical use.
For manufacturers developing new pesticides, herbicides, fungicides, and biological crop protection products, food-residue considerations remain an important part of the overall regulatory strategy.
Agrochemical companies cannot rely on regulatory policy monitoring alone. The scientific data package remains fundamental to registration.
EPA states that pesticide registration is a scientific, legal, and administrative process involving the evaluation of ingredients, proposed crops and uses, application rates, timing, storage, disposal, and potential human-health and environmental effects.
Companies therefore need to prepare extensive information covering areas such as:
Product chemistry.
Toxicology.
Environmental fate.
Ecotoxicology.
Residue behavior.
Exposure assessment.
Efficacy.
Labeling.
Manufacturing information.
Changes in agency leadership may influence priorities or implementation, but they do not eliminate the underlying scientific and statutory requirements.
Leadership transitions can become particularly relevant for companies developing novel crop protection technologies.
These may include:
Biopesticides.
Microbial products.
RNA-based crop protection.
Novel synthetic molecules.
Biological active ingredients.
Precision crop protection technologies.
New formulations.
EPA maintains separate registration pathways and requirements for different pesticide categories, including biopesticides and conventional pesticides.
For emerging technologies, regulatory interpretation and agency priorities can influence how companies plan testing programs, data generation, product claims, and commercialization timelines.
Federal registration is not always the final regulatory step.
EPA's framework also recognizes state-specific registrations under FIFRA Section 24(c) for certain special local needs. States can register additional uses or certain products under specified conditions, while EPA retains oversight of the process.
This creates another consideration for agrochemical manufacturers planning market entry.
Companies may need to evaluate:
Federal EPA registration.
Food-residue and tolerance requirements.
State-specific requirements.
Product labeling.
Manufacturing and establishment obligations.
Post-registration compliance.
Regulatory transitions can also affect commercial planning even when the underlying rules remain unchanged.
Agrochemical manufacturers and distributors must consider how regulatory decisions affect:
Product launch timing.
Inventory planning.
Import schedules.
Manufacturing commitments.
Contract manufacturing.
Supplier qualification.
Market-entry strategies.
This is particularly important for products manufactured outside the United States and imported into the market.
EPA requires pesticide-producing establishments, including relevant foreign establishments associated with imports, to meet establishment registration and reporting requirements under FIFRA.
As a result, regulatory compliance is closely connected to supply-chain planning.
The FDA transition should therefore be viewed as one component of a wider regulatory-monitoring strategy.
Agrochemical companies should track:
FDA leadership and food-safety priorities.
EPA Office of Pesticide Programs policies.
New pesticide registration guidance.
FIFRA and FFDCA developments.
Residue and tolerance decisions.
Biopesticide regulatory developments.
State-level registration changes.
Electronic submission requirements.
Registration-review decisions.
Monitoring both FDA and EPA is particularly important for companies whose products involve food-producing crops.
Procurement teams may also be affected indirectly.
When regulatory timelines change or new requirements emerge, buyers may need to reassess sourcing plans for active ingredients, intermediates, formulations, and technical materials.
A product facing regulatory uncertainty may carry greater inventory or supply risk than an established product with a stable registration history.
For chemical marketplaces, regulatory intelligence can therefore become a valuable part of supplier and product information. Buyers could benefit from visibility into:
Registration status.
Approved uses.
Active-ingredient status.
Country-specific regulatory approvals.
Product labels.
Tolerance information.
Supplier compliance status.
The current FDA leadership transition is unlikely to fundamentally transfer U.S. pesticide registration authority away from EPA. Instead, its significance for agrochemicals lies in the interaction between pesticide regulation, food safety, and federal regulatory priorities.
With Kyle Diamantas continuing as Acting Commissioner in August 2026, FDA's food-policy direction remains relevant to agricultural stakeholders, particularly where pesticide residues and food safety intersect.
Meanwhile, EPA remains the central agency for pesticide registration under FIFRA and continues to maintain registration procedures, data requirements, and guidance for agricultural chemicals.
The 2026 FDA leadership transition carries indirect but meaningful relevance for agrochemical registration pathways.
EPA remains the primary U.S. authority for registering pesticides, while FDA's role is more closely connected to food safety and the broader regulatory framework governing pesticide residues in food.
For agrochemical manufacturers, the key lesson is that regulatory monitoring should not focus on a single agency. Companies developing or commercializing crop protection products need to follow both EPA pesticide policy and FDA food-safety priorities, alongside state-level requirements.
As regulatory expectations evolve, companies that integrate regulatory intelligence into product development, procurement, supply-chain planning, and market-entry strategies will be better positioned to manage uncertainty and avoid delays.
Featured Product
Found this useful?
Continue Reading
Recurring Rhine disruptions are becoming a persistent operational risk for Germany's chemical industry in 2026, affecting vessel capacity, logistics costs, production planning and the resilience of Europe's interconnected chemical supply chains.
Pharmaceutical industry leaders are assessing what Heidi Overton's nomination to lead the FDA could mean for drug approval standards, review timelines and regulatory policy. The appointment comes as the agency works through leadership turnover and efforts to accelerate drug development.
BASF's Ludwigshafen workforce falling below 30,000 for the first time since 1954 ranks among 2026's most symbolic European chemical contraction milestones, highlighting the industry's shift toward leaner operations and more competitive assets.
